Skip to main content
SpringerLink
Log in

Problems associated with the clinical use of radiopharmaceuticals: a proposed classification system and troubleshooting guide

  • Occasional Survey
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Problems associated with the clinical use of radiopharmaceuticals can usually be classified into one of four categories: unusual imaging results, adverse reactions, unique difficulties encountered in special patient populations, and quality assurance failures. Each of these problem areas is briefly described and a guide for troubleshooting such problems is presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Strand LM, Cipolle RJ, Morley PL.Pharmaceutical care: an introduction. Kalamazoo, Mich.: Upjohn, 1992 (published as part of the Current Concepts series)

    Google Scholar 

  2. Strand LM, Morley PL, Cipolle RJ, et al. Drug-related problems: their structure and function.DICP Ann Pharmacother 1990; 24: 1093–1097.

    Google Scholar 

  3. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care.Am J Hosp Pharm 1990; 47: 533–543.

    PubMed  Google Scholar 

  4. Silberstein EB. Adverse reactions of radiopharmaceutical agents. In. Henkin RE, ed.Nuclear medicine. St. Louis: Mosby Year Book; 1996: 485–492.

    Google Scholar 

  5. Keeling DH. Adverse reactions and untoward events associated with the use of radiopharmaceutical. In: Sampson CB, ed.Textbook of radiopharmacy, theory and practice. Amsterdam: Gordon and Breach Science Publishers/Harwood Academic Publishers; 1995: 285–298.

    Google Scholar 

  6. Hladik WB, Norenberg JP, Sampson CB. Drug interactions with radiopharmaceuticals: an overview of the concept. In: Sampson CB, Hladik WB, Laven DL, eds.International handbook of drug- radiopharmaceutical interactions. London: Harward Academic Publishers, in press.

  7. Gilbert S, LeBlanc AD, Schleipman R, et al.Quality assurance resource manual for nuclear medicine. New York: Society of Nuclear Medicine, 1990.

    Google Scholar 

  8. Rhodes BA, ed.Quality control in nuclear medicine: radiopharmaceuticals, instrumentation, and in-vitro assays. St. Louis: Mosby, 1977.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of New Mexico, 87131, Albuquerque, New Mexico, USA

    Wiliam B. Hladik III & Jeffrey P. Norenberg

Authors
  1. Wiliam B. Hladik III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey P. Norenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hladik, W.B., Norenberg, J.P. Problems associated with the clinical use of radiopharmaceuticals: a proposed classification system and troubleshooting guide. Eur J Nucl Med 23, 997–1002 (1996). https://doi.org/10.1007/BF01084379

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01084379

Key words

Search

Navigation